人工智能能预测癌症风险,我们已经到了吗? 在癌症类型中进行全面的综述
Alessio Felici1, Giulia Peduzzi1, Roberto Pellungrini2
1Department of Biology, University of Pisa, Via Luca Ghini, 13, Pisa 56126, Italy.
概括
人工智能 (AI) 为癌症风险预测提供了先进的解决方案,克服了传统模型的局限性. 本综述探讨了19种癌症类型的AI应用,评估了它们在临床实践中的潜力.
科学领域:
- 在瘤学瘤学.
- 生物信息学是一种生物信息学.
- 医疗信息学 医疗信息学
背景情况:
- 癌症是全球主要的死亡原因,给公共卫生带来了重大挑战.
- 癌症风险预测的传统流行病学模型在复杂的多维数据方面存在局限性.
- 人工智能 (AI) 是一个有希望的方法来克服癌症研究中的这些局限性.
研究的目的:
- 审查人工智能技术的现状及其适用于癌症研究中的各种数据类型的适用性.
- 综合分析AI在19种不同的癌症类型中的应用.
- 讨论人工智能的临床整合,局限性和瘤学的未来前景.
主要方法:
- 检查人工智能技术的现状,包括它们的优势和数据类型兼容性.
- 对人工智能在膀,乳腺,宫,结直肠,子宫内膜,食道,胃,妇科,头,血液,脏,肝脏,肺,黑色素瘤,卵巢,胰腺,前列腺,甲状腺和整体癌症中的应用进行系统的文献分析.
- 在癌症预测研究中使用的AI模型,性能指标和暴露变量的评估.
主要成果:
- 人工智能技术显示出在大型异质癌症数据集中识别复杂模式的潜力.
- 该审查涵盖了广泛的癌症,详细介绍了特定的人工智能模型应用及其评估结果.
- 分析突出了AI模型实施和报告在不同癌症类型中的差异.
结论:
- 人工智能提供了一个强大的工具,可以超越传统的流行病学方法来提高癌症风险预测.
- 人工智能在瘤学中的应用正在扩大,对临床实践有很大的潜力.
- 需要进一步的研究来解决局限性问题,并优化人工智能集成,以改善癌症结果.
更多相关视频
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
8.8K
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.4K
相关概念视频
Cancer Survival Analysis
313
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
313
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer Prevention
6.0K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.0K
Cancer Vaccines
310
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
310
Cancer
47.3K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
47.3K
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
